0,851  0,002  Histamine H1 receptor antagonist
0,672  0,004  Antihistaminic
0,668  0,004  Histamine antagonist
0,587  0,002  Menstruation disorders treatment
0,554  0,031  Analgesic, non-opioid
0,537  0,039  Analgesic
0,513  0,023  CYP2D6 substrate
0,464  0,013  Sedative
0,482  0,044  CYP3A4 substrate
0,450  0,016  Anticonvulsant
0,432  0,039  5 Hydroxytryptamine release stimulant
0,390  0,016  Antiparkinsonian, rigidity relieving
0,434  0,062  Antiparkinsonian
0,368  0,004  Dysmenorrhea treatment
0,403  0,064  Antiobesity
0,389  0,053  Antiallergic
0,340  0,006  Liver cirrhosis treatment
0,381  0,057  Mood disorders treatment
0,376  0,052  Antidepressant
0,332  0,020  Antimigraine
0,378  0,076  Antipruritic, allergic
0,320  0,031  Platelet aggregation inhibitor
0,340  0,055  Antiepileptic
0,344  0,060  Anxiolytic
0,289  0,016  Antipruritic
0,278  0,006  VEGF expression inhibitor
0,331  0,061  Antipsychotic
0,327  0,059  CYP2D6 inhibitor
0,340  0,083  Cognition disorders treatment
0,310  0,066  Spasmolytic
0,255  0,026  Antiparkinsonian, tremor relieving
0,246  0,021  Age-related macular degeneration treatment
0,248  0,029  Cholinergic
0,223  0,006  Pregnane X receptor agonist
0,281  0,067  CYP1A2 inhibitor
0,318  0,104  GABA C receptor rho-3 antagonist
0,245  0,034  Amyloid beta precursor protein antagonist
0,211  0,013  Antiinfertility, female
0,227  0,033  Skeletal muscle relaxant
0,196  0,004  Mental retardation treatment
0,201  0,014  Acetylcholine agonist
0,217  0,035  Acetylcholine M1 receptor antagonist
0,188  0,007  Acetylcholine muscarinic agonist
0,188  0,008  SULT1E1 substrate
0,210  0,031  Insulin secretagoues
0,218  0,042  UGT1A3 substrate
0,195  0,026  Rhinitis treatment
0,274  0,111  Vasodilator, peripheral
0,185  0,023  MAP3K9 inhibitor
0,181  0,020  5 Hydroxytryptamine 2C antagonist
0,291  0,134  CYP2C19 inhibitor
0,322  0,171  Caspase 9 stimulant
0,179  0,031  5 Hydroxytryptamine 2B antagonist
0,307  0,161  Alzheimer's disease treatment
0,212  0,066  Neurotrophic factor enhancer
0,151  0,007  Acetylcholine M1 receptor agonist
0,158  0,015  Acetylcholine M3 receptor agonist
0,198  0,057  Muscle relaxant
0,169  0,036  Platelet activating factor antagonist
0,222  0,090  Acute neurologic disorders treatment
0,211  0,079  Dependence treatment
0,135  0,005  Farnesyltransferase inhibitor
0,268  0,142  Histamine release inhibitor
0,199  0,075  Anesthetic general
0,243  0,122  CYP3A4 inhibitor
0,135  0,013  Acetylcholine M4 receptor antagonist
0,216  0,096  Tumour necrosis factor alpha release inhibitor
0,170  0,051  Raynaud's phenomenon treatment
0,137  0,017  Tourette's syndrome treatment
0,149  0,031  HDL-cholesterol increasing
0,164  0,046  Allergic rhinitis treatment
0,158  0,046  Antieczematic
0,121  0,010  Acetylcholine M5 receptor agonist
0,147  0,036  Interleukin 8 antagonist
0,148  0,039  Alpha 2b adrenoreceptor antagonist
0,127  0,018  Dopamine D1 antagonist
0,219  0,110  Antineoplastic (bladder cancer)
0,129  0,023  Lanosterol 14 alpha demethylase inhibitor
0,206  0,102  Heart failure treatment
0,119  0,016  Benzodiazepine agonist
0,162  0,059  GABA C receptor rho-2 antagonist
0,121  0,020  Histamine H2 receptor antagonist
0,146  0,046  5 Hydroxytryptamine 2 antagonist
0,228  0,128  Ca2+/calmodulin-dependent kinase II alpha inhibitor
0,115  0,018  Calcium channel L-type blocker
0,200  0,104  MAP-kinase-activated kinase 5 inhibitor
0,194  0,098  Cyclic AMP phosphodiesterase inhibitor
0,145  0,050  Antismoking
0,100  0,004  Acetylcholine M4 receptor agonist
0,118  0,024  5 Hydroxytryptamine 1F antagonist
0,234  0,140  Antithrombotic
0,106  0,014  5 Hydroxytryptamine 5A antagonist
0,100  0,009  Potassium channel intermediate-conductance Ca-activated blocker
0,168  0,077  Toxic, respiratory center
0,118  0,027  Gastroesophageal reflux disease treatment
0,116  0,026  Bromodomain-containing protein 2 inhibitor
0,104  0,014  5 Hydroxytryptamine 5 antagonist
0,203  0,114  Neuropeptide Y2 antagonist
0,285  0,197  MAP kinase 1 inhibitor
0,187  0,099  Antineoplastic enhancer
0,146  0,061  Interleukin 1 antagonist
0,105  0,022  Amidase inhibitor
0,226  0,143  Antihypertensive
0,088  0,010  Acetylcholine M2 receptor agonist
0,128  0,050  GABA receptor agonist
0,199  0,121  Antiprotozoal (Trypanosoma)
0,108  0,031  Tocolytic
0,102  0,027  Dopamine agonist
0,115  0,040  Antineoplastic alkaloid
0,215  0,139  Hepatic disorders treatment
0,140  0,066  Cachexia treatment
0,120  0,048  Acetylcholine release stimulant
0,172  0,102  Ca2+/calmodulin-dependent kinase II beta inhibitor
0,096  0,026  Viral attachment inhibitor
0,229  0,161  Stroke treatment
0,166  0,099  Sepsis treatment
0,121  0,055  Calcium channel (voltage-sensitive) blocker
0,130  0,065  Glutamate receptor antagonist
0,092  0,029  Cushing's syndrome treatment
0,072  0,010  G protein-coupled receptor agonist
0,077  0,014  5 Hydroxytryptamine 4 antagonist
0,180  0,118  Antihypercholesterolemic
0,075  0,014  Oleamide hydrolase inhibitor
0,239  0,177  CYP2C9 inhibitor
0,134  0,074  Nav1.6 sodium channel blocker
0,104  0,044  5 Hydroxytryptamine 2A antagonist
0,101  0,043  Restless leg syndrome treatment
0,085  0,027  Acetylcholine M2 receptor antagonist
0,132  0,075  Calcium channel blocker
0,121  0,066  Acetylcholine muscarinic antagonist
0,187  0,132  Cardiotonic
0,078  0,025  Alpha 2 adrenoreceptor agonist
0,063  0,010  Benzodiazepine antagonist
0,110  0,057  Alpha 2c adrenoreceptor antagonist
0,103  0,051  Posttraumatic stress disorder treatment
0,082  0,030  5 Hydroxytryptamine 7 antagonist
0,171  0,120  Potassium channel (Voltage-sensitive) blocker
0,064  0,014  Cholesterol esterase inhibitor
0,059  0,008  Glucose-dependent insulinotropic receptor agonist
0,131  0,081  Farnesoid X receptor antagonist
0,132  0,084  UGT2B15 substrate
0,115  0,068  5 Hydroxytryptamine antagonist
0,202  0,155  Nootropic
0,151  0,105  Sleep disorders treatment
0,221  0,176  CYP2C9 substrate
0,111  0,066  Myasthenia Gravis treatment
0,071  0,026  Calcium channel P-type blocker
0,068  0,024  Autotaxin inhibitor
0,093  0,050  Phosphodiesterase IV inhibitor
0,111  0,069  TRPA1 agonist
0,117  0,077  Cholinergic antagonist
0,113  0,074  Autism spectrum disorders treatment
0,075  0,037  5 Hydroxytryptamine 1B antagonist
0,078  0,039  Alpha adrenoreceptor agonist
0,058  0,021  Histamine H4 receptor antagonist
0,072  0,038  Purinergic P2 antagonist
0,090  0,056  Histamine N-methyltransferase inhibitor
0,175  0,142  RNA-directed DNA polymerase inhibitor
0,095  0,061  Bile acid receptor antagonist
0,076  0,043  Glycine receptor agonist
0,066  0,033  Prolactin release inhibitor
0,055  0,022  Dopamine D5 antagonist
0,084  0,052  Transforming growth factor beta 3 antagonist
0,106  0,074  Nav1.5 sodium channel blocker
0,163  0,131  Fibrosis treatment
0,051  0,020  Glutamate (mGluR1a) antagonist
0,106  0,075  Interleukin 1b antagonist
0,186  0,155  Radiosensitizer
0,100  0,070  Mediator release inhibitor
0,054  0,024  Dopamine D2 agonist
0,147  0,118  Antiarrhythmic
0,109  0,080  Acetylcholine antagonist
0,087  0,058  Alpha 2 adrenoreceptor antagonist
0,111  0,083  Bipolar disorder treatment
0,154  0,127  CYP2B6 inhibitor
0,069  0,043  Female sexual dysfunction treatment
0,036  0,010  Purinergic P2Y12 antagonist
0,245  0,219  Cyclophilin D inhibitor
0,245  0,219  Antidiabetic
0,104  0,079  Antitussive
0,128  0,103  UGT1A4 substrate
0,051  0,027  5 Hydroxytryptamine 2C agonist
0,067  0,043  Uterine relaxant
0,057  0,033  GABA A receptor antagonist
0,214  0,192  Calcium channel activator
0,250  0,228  5 Hydroxytryptamine release inhibitor
0,045  0,024  Antidiuretic hormone antagonist
0,151  0,130  HERG channel blocker
0,092  0,071  Antiemetic
0,054  0,033  5 Hydroxytryptamine 2 agonist
0,119  0,098  Activin receptor-like kinase 2 inhibitor
0,062  0,041  Narcolepsy treatment
0,081  0,060  Antiviral (RSV)
0,182  0,163  Flavin-containing monooxygenase substrate
0,105  0,087  Calcium channel N-type blocker
0,156  0,138  Platelet antagonist
0,042  0,025  Acid-sensing ion channel blocker
0,046  0,029  Histamine H3 receptor antagonist
0,054  0,038  GABA receptor antagonist
0,054  0,038  Lysine-specific demethylase 1A inhibitor
0,067  0,051  Elastase 1 inhibitor
0,175  0,160  Amyotrophic lateral sclerosis treatment
0,064  0,050  Phosphodiesterase 4B inhibitor
0,035  0,021  ADAM10 endopeptidase inhibitor
0,043  0,031  Alpha 1L adrenoreceptor agonist
0,127  0,116  Male reproductive disfunction treatment
0,039  0,027  5 Hydroxytryptamine 2B agonist
0,111  0,100  Attention deficit/hyperactivity disorder treatment
0,034  0,024  Benzodiazepine receptor peripheral-type antagonist
0,193  0,183  ICAM1 expression inhibitor
0,137  0,127  Hearing loss treatment
0,024  0,015  CC chemokine 8 receptor antagonist
0,068  0,060  Alpha 2a adrenoreceptor antagonist
0,174  0,168  Renal disease treatment
0,076  0,069  Ca(v)2.2 blocker
0,103  0,097  CNS active muscle relaxant
0,012  0,008  Glucose-dependent insulinotropic receptor antagonist
0,150  0,146  Antineoplastic (lymphoma)
0,026  0,023  Nicotinic alpha4beta2 receptor agonist
0,035  0,032  Vascular adhesion protein 1 inhibitor
0,101  0,098  Sphingosine 1-phosphate receptor 2 agonist
0,051  0,049  Dopamine D4 antagonist
0,108  0,106  Antihelmintic (Trematoda)
0,182  0,180  CYP1A2 substrate
0,018  0,017  Purinergic P2T antagonist
0,041  0,040  Glutamate (mGluR5) antagonist
0,035  0,035  Secretase gamma inhibitor

